IN8bio, Inc. (INAB)
NASDAQ: INAB · IEX Real-Time Price · USD
0.808
-0.005 (-0.59%)
Jul 2, 2024, 4:00 PM EDT - Market closed
IN8bio Market Cap
IN8bio has a market cap or net worth of $35.67 million as of July 2, 2024. Its market cap has decreased by -31.94% in one year.
Market Cap
35.67M
Enterprise Value
28.37M
1-Year Change
-31.94%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $35.67M, a decrease of -80.98%. That is a compound annual growth rate of -43.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 35.70M | -19.05% |
| Dec 29, 2023 | 44.10M | -22.08% |
| Dec 30, 2022 | 56.60M | -31.23% |
| Dec 31, 2021 | 82.30M | -56.12% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytosorbents | 38.18M |
| Reviva Pharmaceuticals Holdings | 38.17M |
| Immuneering | 37.96M |
| ImmuCell | 37.89M |
| Nortech Systems | 37.63M |
| Owlet | 37.28M |
| Cyclo Therapeutics | 36.34M |
| Aadi Bioscience | 35.85M |